Table 1.
Patient characteristics.
| All |
3 SAX |
3 SAX + 3 LAX |
6 SAX |
|
|---|---|---|---|---|
| (n = 287) | (n = 83) | (n = 103) | (n = 101) | |
| Age (range) | 66 (18–88) | 67 (30–88) | 66 (18–88) | 65 (27–85) |
| Sex (females) | 122 (43%) | 40 (48%) | 41 (40%) | 43 (43%) |
| Smoker | 25 (9%) | 9 (11%) | 6 (6%) | 10 (10%) |
| Current | 10 (3%) | 4 (5%) | 1 (1%) | 5 (5%) |
| Former | 15 (5%) | 5 (6%) | 5 (5%) | 5 (5%) |
| Diabetes | 38 (13%) | 8 (10%) | 17 (17%) | 13 (13%) |
| Hypertension | 90 (31%) | 25 (30%) | 35 (34%) | 30 (30%) |
| Known CAD | 48 (17%) | 16 (19%) | 14 (14%) | 18 (18%) |
| Prior PCI | 45 (16%) | 13 (16%) | 15 (15%) | 17 (17%) |
| Prior CABG | 19 (7%) | 2 (2%) | 5 (5%) | 12 (12%) |
| Statins | 103 (36%) | 30 (36%) | 30 (29%) | 43 (43%) |
| ACE-inh/ARB | 97 (34%) | 25 (30%) | 31 (30%) | 41 (41%) |
| Anticoagulants | 118 (41%) | 38 (46%) | 36 (35%) | 44 (44%) |
Data expressed as median and range or absolute numbers and proportion.
ACE-inh angiotension-converting enzyme inhibitor, ARB angiotensin II receptor blockers, CABG coronary artery bypass grafting, CAD coronary artery disease, LAX long-axis views, PCI percutaneous coronary intervention, SAX short-axis views.